Aberrant blood cell division cycle 42 expression and its correlation with disease severity, inflammation and mortality risk in patients with acute pancreatitis

Yang,Jun; Li,Xiaoqian; Yang,Xuefeng; Wei,Hongjiang; Deng,Lipu; Fu,Nian

doi:10.3892/etm.2022.11385

Aberrant blood cell division cycle 42 expression and its correlation with disease severity, inflammation and mortality risk in patients with acute pancreatitis

Authors:
- Jun Yang
- Xiaoqian Li
- Xuefeng Yang
- Hongjiang Wei
- Lipu Deng
- Nian Fu
View Affiliations

Affiliations: Department of Emergency, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421000, P.R. China, Department of Gastroenterology, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421000, P.R. China
Published online on: May 20, 2022 https://doi.org/10.3892/etm.2022.11385
Article Number: 458
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cell division cycle 42 (CDC42) can inhibit inflammation by regulating the activity of macrophage and T cells, which contributes to the pathophysiology of acute pancreatitis (AP). Therefore, CDC42 may have application as a potential biomarker for AP. The present study aimed to explore this possibility. Peripheral blood mononuclear cells (PBMCs) were collected from 149 patients with AP and 50 healthy controls (HCs). Subsequently, CDC42 expression in the PBMCs was measured using RT‑qPCR; C‑reactive protein (CRP), TNF‑α and IL‑6 in the serum of patients with AP were measured using ELISA. Meanwhile, Mann‑Whitney U test, Kruskal‑Wallis test, and Spearman's rank correlation test were performed on the data. The CDC42 expression levels were lower in patients with AP compared with those in HCs (P<0.001). CDC42 expression was declined in patients with moderate‑severe AP (MSAP) vs. patients with mild AP (MAP) (P=0.029), and in patients with severe AP (SAP) vs. patients with MAP (P=0.004). CDC42 expression correlated negatively with the Ranson's score (P<0.001), APACEH II score (P=0.011) and SOFA score (P<0.001) in patients with AP. CDC42 expression also correlated negatively with CRP (P<0.001) and TNF‑α (P=0.004) levels but not with IL‑6 levels (P=0.177). Furthermore, CDC42 expression was lower in deceased patients with AP vs. AP survivors (P<0.001) and in deceased patients with SAP vs. SAP survivors (P=0.026). CDC42 had good potential in predicting mortality from AP, with AUC of 0.829 and a 95% CI of 0.731‑0.927, and it also had certain potential in predicting mortality from SAP and MSAP, with AUC (95% CI) of 0.794 (0.616‑0.973) and 0.757 (0.558‑0.956), respectively. In conclusion, data from the present study suggest that lower CDC42 expression levels correlate with higher disease susceptibility, disease severity, inflammation, and mortality risk in patients with AP.

View Figures

View References

1	Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, van Santvoort HC and Besselink MG: Acute pancreatitis. Lancet. 396:726–734. 2020.PubMed/NCBI View Article : Google Scholar
2	Lee PJ and Papachristou GI: New insights into acute pancreatitis. Nat Rev Gastroenterol Hepatol. 16:479–496. 2019.PubMed/NCBI View Article : Google Scholar
3	Petrov MS and Yadav D: Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 16:175–184. 2019.PubMed/NCBI View Article : Google Scholar
4	Trikudanathan G, Wolbrink DRJ, van Santvoort HC, Mallery S, Freeman M and Besselink MG: Current concepts in severe acute and necrotizing pancreatitis: An evidence-based approach. Gastroenterology. 156:1994–2007 e3. 2019.PubMed/NCBI View Article : Google Scholar
5	Mandalia A, Wamsteker EJ and DiMagno MJ: Recent advances in understanding and managing acute pancreatitis. F1000Res 7: F1000 Faculty Rev-959, 2018.
6	Siegel RL, Miller KD, Fuchs HE and Jemal A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.PubMed/NCBI View Article : Google Scholar
7	Tempero MA, Malafa MP, Al-Hawary M, Behrman SW, Benson AB, Cardin DB, Chiorean EG, Chung V, Czito B, Del Chiaro M, et al: Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 19:439–457. 2021.PubMed/NCBI View Article : Google Scholar
8	Pichaud F, Walther RF and Nunes de Almeida F: Regulation of Cdc42 and its effectors in epithelial morphogenesis. J Cell Sci. 132(jcs217869)2019.PubMed/NCBI View Article : Google Scholar
9	Liu Y, Dou Y, Yan L, Yang X, He B, Kong L and Smith W: The role of Rho GTPases' substrates Rac and Cdc42 in osteoclastogenesis and relevant natural medicinal products study. Biosci Rep. 40(BSR20200407)2020.PubMed/NCBI View Article : Google Scholar
10	Kalim KW, Yang JQ, Li Y, Meng Y, Zheng Y and Guo F: Reciprocal regulation of glycolysis-driven Th17 pathogenicity and regulatory T cell stability by Cdc42. J Immunol. 200:2313–2326. 2018.PubMed/NCBI View Article : Google Scholar
11	Guo F: RhoA and Cdc42 in T cells: Are they targetable for T cell-mediated inflammatory diseases? Precis Clin Med. 4:56–61. 2021.PubMed/NCBI View Article : Google Scholar
12	Cao J, Zhang C, Jiang GQ, Jin SJ, Wang Q, Wang AQ and Bai DS: Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses. Bioengineered. 12:296–309. 2021.PubMed/NCBI View Article : Google Scholar
13	Zhang B, Zhang J, Xia L, Luo J, Zhang L, Xu Y, Zhu X and Chen G: Inhibition of CDC42 reduces macrophage recruitment and suppresses lung tumorigenesis in vivo. J Recept Signal Transduct Res. 41:504–510. 2021.PubMed/NCBI View Article : Google Scholar
14	Zhen J, Chen W, Liu Y and Zang X: Baicalin protects against acute pancreatitis involving JNK signaling pathway via regulating miR-15a. Am J Chin Med. 49:147–161. 2021.PubMed/NCBI View Article : Google Scholar
15	Wang H, Jiang Y, Li H, Wang J, Li C and Zhang D: Carbachol protects the intestinal barrier in severe acute pancreatitis by regulating Cdc42/F-actin cytoskeleton. Exp Ther Med. 20:2828–2837. 2020.PubMed/NCBI View Article : Google Scholar
16	Foster BR, Jensen KK, Bakis G, Shaaban AM and Coakley FV: Revised Atlanta classification for acute pancreatitis: A pictorial essay. Radiographics. 36:675–687. 2016.PubMed/NCBI View Article : Google Scholar
17	Knaus WA, Draper EA, Wagner DP and Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med. 13:818–829. 1985.PubMed/NCBI
18	Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM and Thijs LG: The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine. Intensive Care Med. 22:707–710. 1996.PubMed/NCBI View Article : Google Scholar
19	Sun N, Ye L, Chang T and Li X and Li X: microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 7:6871–6879. 2014.PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
21	Tang WJ, Peng KY, Tang ZF, Wang YH, Xue AJ and Huang Y: MicroRNA-15a-cell division cycle 42 signaling pathway in pathogenesis of pediatric inflammatory bowel disease. World J Gastroenterol. 24:5234–5245. 2018.PubMed/NCBI View Article : Google Scholar
22	Veluthakal R and Thurmond DC: Emerging roles of small GTPases in islet β-cell function. Cells. 10(1503)2021.PubMed/NCBI View Article : Google Scholar
23	Chundru SA, Harajli A, Hali M, Gleason N, Gamage S and Kowluru A: RhoG-Rac1 signaling pathway mediates metabolic dysfunction of the pancreatic beta-cells under chronic hyperglycemic conditions. Cell Physiol Biochem. 55:180–192. 2021.PubMed/NCBI View Article : Google Scholar
24	He XQ, Wang N, Zhao JJ, Wang D, Wang CJ, Xie L, Zheng HY, Shi SZ, He J, Zhou J, et al: Specific deletion of CDC42 in pancreatic beta cells attenuates glucose-induced insulin expression and secretion in mice. Mol Cell Endocrinol. 518(111004)2020.PubMed/NCBI View Article : Google Scholar
25	Habtezion A, Gukovskaya AS and Pandol SJ: Acute pancreatitis: A multifaceted set of organelle and cellular interactions. Gastroenterology. 156:1941–1950. 2019.PubMed/NCBI View Article : Google Scholar
26	Garg PK and Singh VP: Organ failure due to systemic injury in acute pancreatitis. Gastroenterology. 156:2008–2023. 2019.PubMed/NCBI View Article : Google Scholar
27	Woods B and Lew DJ: Polarity establishment by Cdc42: Key roles for positive feedback and differential mobility. Small GTPases. 10:130–137. 2019.PubMed/NCBI View Article : Google Scholar
28	Li Z, Wu J, Zhang X, Ou C, Zhong X, Chen Y, Lu L, Liu H, Li Y, Liu X, et al: CDC42 promotes vascular calcification in chronic kidney disease. J Pathol. 249:461–471. 2019.PubMed/NCBI View Article : Google Scholar
29	Li J, Liu Y, Jin Y, Wang R, Wang J, Lu S, VanBuren V, Dostal DE, Zhang SL and Peng X: Essential role of Cdc42 in cardiomyocyte proliferation and cell-cell adhesion during heart development. Dev Biol. 421:271–283. 2017.PubMed/NCBI View Article : Google Scholar
30	Leppäniemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E, Kirkpatrick AW, Ball CG, Parry N, Sartelli M, Wolbrink D, et al: 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 14(27)2019.PubMed/NCBI View Article : Google Scholar
31	Jinno N, Hori Y, Naitoh I, Miyabe K, Yoshida M, Natsume M, Kato A, Asano G, Sano H and Hayashi K: Predictive factors for the mortality of acute pancreatitis on admission. PLoS One. 14(e0221468)2019.PubMed/NCBI View Article : Google Scholar
32	Dancu GM, Popescu A, Sirli R, Danila M, Bende F, Tarta C and Sporea I: The BISAP score, NLR, CRP, or BUN: Which marker best predicts the outcome of acute pancreatitis? Medicine (Baltimore). 100(e28121)2021.PubMed/NCBI View Article : Google Scholar